WHO ICTRP trial
A multi-centre, multinational clinical study to investigate the safety and…
ISRCTN82615441 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN82615441 |
|---|---|
| Public title | A multi-centre, multinational clinical study to investigate the safety and effectiveness of intravenous infusions of VIT-45 (Ferinject) in patients with iron deficiency anaemia (IDA) caused by chronic inflammatory bowel disease (IBD) in comparison with oral iron capsules |
| Scientific title | A multi-centre, randomised, controlled, phase iii study to investigate the safety and efficacy of intravenous infusions of VIT-45 in patients with iron deficiency anaemia secondary to chronic inflammatory bowel disease |
| Primary sponsor | Vifor (International) Inc. |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase III |
| Countries | Argentina;Austria;Belgium;Bulgaria;Mexico;Poland;Russian Federation;Ukraine |
| Conditions | Iron deficiency anaemia secondary to chronic inflammatory bowel disease Signs and Symptoms |
| Interventions | 1. Patients in the experimental arm received VIT-45 as an infusion on Day 1, with subsequent infusions at weekly intervals up to a maximum of 1000 mg iron per dose. The doses were continued until the patient received the cumulative dose… |
| Registration date | May 26, 2015 |
| Target size | 252 |
| Secondary IDs | VIT-IV-CL-008 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: